SANTA CLARA, Calif.--(BUSINESS WIRE)--
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release
its third quarter financial results on November 5, 2008, at
approximately 4:30 p.m. Eastern Time. The company will host a
conference call at 5:00 p.m. Eastern Time that same day. A replay of
the call will be available for one week following the event.
To access the conference call via the Internet, go to
www.XenoPort.com. Please join the call at least 15 minutes prior to
the start to ensure time for any software downloads that may be
To access the live conference call via phone, dial 1-888-275-3514.
International callers may access the live call by dialing
706-679-1417. The reference number to enter the call is 68806524.
The replay of the conference call may be accessed that same day
after 8:00 p.m. Eastern Time, via the Internet, at www.XenoPort.com,
or via phone at 1-800-642-1687 for domestic callers, or 706-645-9291
for international callers. The reference number to enter the replay of
the call is 68806524.
XenoPort, Inc. is a biopharmaceutical company focused on
developing a portfolio of internally discovered product candidates
that utilize the body's natural nutrient transport mechanisms to
improve the therapeutic benefits of existing drugs. XenoPort is
developing its lead product candidate in partnership with Astellas
Pharma Inc. and GlaxoSmithKline. GlaxoSmithKline has filed with the
U.S. Food and Drug Administration a new drug application for this
product candidate, known as Solzira(TM) in the U.S., for the treatment
of restless legs syndrome. XenoPort's product candidates are also
being studied for the potential treatment of gastroesophageal reflux
disease, migraine headaches, neuropathic pain, spasticity related to
spinal chord injury, acute back spasms and Parkinson's disease.
To learn more about XenoPort, please visit the Web site at
XenoPort is a registered trademark
Solzira is a U.S. trademark of GSK.
Source: XenoPort, Inc.